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Abstract 
Background and Aims 
Limited information is available regarding links between specific substance use disorders 
(SUDs) and suicide mortality; however, the preliminary evidence that is available suggests that 
suicide risk associated with SUDs may differ for men and women.  This study aimed to estimate 
associations between SUDs and suicide for men and women receiving Veterans Health 
Administration (VHA) care.   
Design 
A cohort study using national administrative health records. 
Setting 
National VHA system, USA. 
Participants 
All VHA users in fiscal year (FY) 2005 who were alive at the beginning of FY 2006 
(n=4,863,086). 
Measurements 
The primary outcome of suicide mortality was assessed via FY 2006-FY 2011 National Death 
Index (NDI) records. Current SUD diagnoses were the primary predictors of interest, and were 
assessed via FY 2004- FY 2005 VHA National Patient Care Database (NPCD) records.     
Findings 
In unadjusted analyses, a diagnosis of any current SUD and the specific current diagnoses of 
alcohol, cocaine, cannabis, opioid, amphetamine, and sedative use disorders were all 
significantly associated with increased risk of suicide for both males and females (hazards ratios 
[HRs] ranging from 1.35 for cocaine use disorder to 4.74 for sedative use disorder for men, and 
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3.89 for cannabis use disorder to 11.36 for sedative use disorder for women).  Further, the HR 
estimates for the relations between any SUD, alcohol, cocaine, and opioid use disorders and 
suicide were significantly stronger for women than men (p<0.05).  After adjustment for other 
factors, most notably comorbid psychiatric diagnoses, associations linking SUDs with suicide 
were markedly attenuated and the greater suicide risk among females was only observed for any 
SUD and opioid use disorder (p<0.05). 
Conclusions 
Current substance use disorders (SUDs) signal increased suicide risk, especially among women, 
and may be important markers to consider including in suicide risk assessment strategies.  
Nonetheless, other co-occurring psychiatric disorders may partially explain associations between 
SUDs and suicide, as well as the observed excess suicide risk associated with SUDs among 
women. 
  
This article is protected by copyright. All rights reserved.
Introduction 
Suicide is a significant global public health concern, responsible for an estimated one 
million deaths annually [1].  In the United States (US), suicide is one of the leading causes of 
death [2].  The US Veterans Health Administration (VHA) is the largest integrated health care 
system in the US, and serves a diverse patient population with elevated suicide risk compared 
with the general US population [3, 4].  Although crude suicide rates are greater for male than 
female VHA patients, sex-specific, age-adjusted standardized mortality ratios (SMRs) indicate 
that suicide rates among female VHA patients are particularly high relative to women in the 
general US population [4, 5].  Consequently, understanding and addressing suicide risk, 
especially among women receiving VHA care, is an important priority.   
In previous analyses regarding diagnostic factors associated with suicide among VHA 
patients, a substance use disorder (SUD) diagnosis was identified as a salient marker of suicide 
risk, especially among women [6, 7].  For example, a report by Ilgen and colleagues found that 
having any SUD diagnosis was associated with a 2.47 times greater risk of completed suicide 
(95% Confidence Interval [CI] 2.30-2.64) [6].  Furthermore, an SUD diagnosis was associated 
with a greater risk of suicide among females than males, with associated hazard ratios (HRs) of 
6.62 (95% Confidence Interval [CI] 4.27-9.29) and 2.27 (95% CI 2.11-2.45), respectively [6].  
Nonetheless, it is currently unknown whether the observed sex difference in suicide risk is 
uniform across all types of SUDs.  In addition, prior analyses have not adjusted for important 
potential confounding factors, in particular co-occurring psychiatric conditions, which are more 
common among individuals with SUD [8, 9].  To inform VHA suicide risk assessment strategies 
and suicide prevention activities, a greater understanding of the sex-specific associations 
between SUDs and suicide is needed. 
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Prior research from other settings has also documented associations between SUDs and 
increased risk of suicidal behaviors [10-12].  Such studies have predominantly investigated 
nonfatal suicide outcomes, namely, suicidal ideation, plans, and attempts; relatively few have 
focused on the specific outcome of suicide death.  Among the studies that have examined suicide 
mortality, the majority have assessed links between alcohol use disorder and suicide, with a 
smaller number of studies exploring the potential role of other SUDs [13].  Notably, the suicide 
risk associated with other common SUDs, including cannabis use disorder and cocaine use 
disorder, remains largely unknown.  Furthermore, the minimal information regarding the suicide 
risk associated with particular SUDs comes from studies estimating individual associations 
between one type of substance and suicide (e.g., only assessing the risk of suicide associated 
with opioid use disorder).  This lack of data on the suicide risk for more than one type of SUD 
from the same data source greatly diminishes the ability to evaluate the extent to which risk 
varies across different types of SUDs, due to differences in populations, study designs, and 
measures between studies.  Preliminary evidence from other settings also suggests that the 
suicide risk associated with SUDs may differ between males and females [6, 13].  Two prior 
meta-analyses found that suicide-specific standardized mortality ratios (SMRs) associated with 
alcohol use disorder were larger for females than males [13, 14].  However, there were an 
insufficient number of studies to estimate similar sex-stratified SMRs for other SUDs.  
Consequently, VHA suicide analyses may have broad public health relevance.     
In the present investigation, we constructed a cohort that included all VHA users who 
obtained care in the VHA system within a single fiscal year (FY), and aimed to: 1) estimate the 
overall and SUD-specific suicide rates among the entire cohort, as well as by sex; 2) estimate 
associations between current SUD diagnoses and the risk of suicide in the six years of follow-up 
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using a series of sex-stratified proportional hazards models; 3) calculate, and compare by SUD 
diagnosis status and sex, percentages of method of suicide among cohort members who died by 
suicide during follow-up.  Analyses were stratified by sex because of the published a-priori 
evidence regarding sex-differences in the suicide risk associated with SUD.   
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Methods 
Design and Data  
 To address the aims of the present study, we conducted a retrospective cohort study in the 
VHA population using national administrative databases.  The study cohort included all VHA 
users who received services in FY 2005 and were alive at the beginning of FY 2006 
(n=4,863,086).  A FY begins on October 1st of the previous calendar year and ends on September 
30th of the calendar year.  The cohort was then assessed for suicide from the beginning of FY 
2006 through the end of FY 2011 (i.e., a six-year follow-up).   
Data for the cohort were drawn from the VHA National Patient Care Database (NPCD) 
and the VHA Suicide Data Repository, which includes search results from the Centers for 
Disease Control and Prevention’s National Death Index (NDI).  The NPCD is a national VHA 
patient medical records database that contains demographic, diagnostic, and treatment 
information for all VHA inpatient and outpatient clinical encounters.  Diagnoses in the NPCD 
are based on clinical judgment, and correspond to the International Classification of Diseases 
Ninth Revision Clinical Modification (ICD-9-CM).  The NDI includes data on the date and cause 
of death for all deaths that occur within the United States, and classifies causes of death 
according to the International Classification of Diseases Tenth Revision Clinical Modification 
(ICD-10-CM).  The NDI records are based on death certificates filed to state vital statistics 
offices.  Prior research has shown that the NDI is the most sensitive population-based vital status 
data source in the United States [15].  The study dataset was created using established 
procedures, and the approach of the present investigation parallels those of previous VHA 
suicide-related evaluation efforts [4, 16, 17].  The project was approved by the VA Ann Arbor 
Institutional Review Board. 
This article is protected by copyright. All rights reserved.
 Measures 
Suicide.  The primary study outcome of interest was suicide during the six years of 
follow-up (i.e., FY 2006- FY 2011).  Deaths by suicide were identified from NDI data using the 
ICD-10-CM codes X60-X84 and Y87.0.  In addition, date of death and method of suicide were 
obtained from the NDI data. 
 
SUDs.  The main predictors of interest were current SUD diagnoses in FY 2004- FY 
2005, which were assessed via NPCD records using ICD-9-CM diagnosis codes.  Major classes 
of SUDs included alcohol, cocaine, cannabis, opioid, amphetamine or other psychostimulant, and 
sedative, hypnotic or anxiolytic use disorders.  In addition, a composite indicator of any current 
SUD was also examined that included any of the aforementioned SUDs, as well as hallucinogen 
use disorder and/or any other/multiple SUDs.  All current SUD diagnoses were based on clinical 
judgment and recorded by VHA healthcare providers (e.g., clinical psychologists) during clinical 
encounters. 
 
Sex.  The stratification variable of male or female sex was ascertained via NPCD 
demographic records. 
 
Covariates.  Several other variables that might confound the relation between SUD and 
the risk of suicide were included as covariates in the adjusted study analyses.  Age in years was 
ascertained via NPCD demographic records, and was divided into the following categories: 18 to 
29, 30 to 39, 40 to 49, 50 to 59, 60 to 69, 70 to 79, or 80 years or older.  Similar to other studies 
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using these data, reliable information on other demographic variables (e.g., race/ethnicity, 
marital status, and employment) was not available, and was consequently not included in 
analyses (e.g., [6]).  The Charlson Comorbidity Index is an established metric that was used to 
assess current non-psychiatric medical comorbidity, including heart disease and cancers, and is 
based on ICD-9-CM clinical diagnostic codes obtained from FY 2004-2005 NPCD records [18].  
Charlson Comorbidity Index scores were recoded into the following categories: 0, 1, or 2 or 
greater.  Current psychiatric diagnoses, which have been shown previously to be associated with 
suicide risk, were assessed via FY 2004-2005 NPCD diagnostic records.  These included the 
presence or absence of each of the following: depression, schizophrenia, bipolar disorder, 
posttraumatic stress disorder, and other anxiety disorders.  
 
Statistical Analysis 
Analyses were conducted on the cohort of 4,863,086 individuals who had VHA 
encounters in FY 2005 and were alive at the beginning of FY 2006.  To begin, we calculated the 
number and percentage of current SUD diagnoses for the entire cohort, as well as by sex.  Next, 
we estimated the overall and SUD-specific suicide rates per 100,000 person-years for the cohort, 
and separately for males and females.  A series of sex-stratified Cox proportional hazards 
regression models was then used to estimate associations between each category of SUD, as well 
as the composite indicator of any SUD, and the risk of suicide, with analyses yielding HRs and 
corresponding 95% confidence intervals (CIs) as the estimates of association [19].  Risk time for 
all cohort members began on the first day of FY 2006 and ended on their recorded date of suicide 
or the last day of FY 2011, if alive.  Cohort members who died from other causes during the 
follow-up interval were censored at the recorded date of their death.  In addition, all proportional 
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hazards models used covariance sandwich estimators to take into account the clustered nature of 
the data, with patients nested within VHA facilities.  The first model in the series estimated the 
unadjusted, bivariate relationship between the given SUD category and risk of suicide mortality.  
The second model adjusted for age group and Charlson Comorbidity.  The third model expanded 
upon the two previous models, with additional adjustment for each of the following co-occurring 
psychiatric conditions: depression, schizophrenia, bipolar disorder, posttraumatic stress disorder, 
and other anxiety disorders.  In additional post-hoc analyses, male-female differences in 
associations between SUDs and suicide were tested using sex by SUD interaction terms in non-
stratified hazards models (i.e., models using the full cohort).  As a final analytic step, we 
calculated percentages of method of suicide among all suicide decedents in the cohort, as well as 
by current SUD status and sex, and performed chi-square analyses to test differences between 
groups.  All data analyses were conducted using SAS 9.3. 
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Results 
 Table 1 displays age group and current SUD diagnostic characteristics of the cohort, 
overall, as well as by sex.  Consistent with the VHA patient population, a majority of the FY 
2005 cohort members were male (n=4,460,447; 91.7%); 402,639 (8.3%) were female.  Age 
distributions varied between men and women, with greater percentages of women in younger age 
groups (p<0.001).  SUD diagnoses also varied by sex, with a greater percentage of males than 
females with at least one SUD diagnosis (males=8.4%; females=3.4%; p<0.001).  Similarly, with 
respect to specific SUD diagnoses, greater percentages of males had current alcohol, cocaine, 
cannabis, opioid, amphetamine, and sedative use disorder diagnoses than females. 
  Table 2 presents suicide information for the entire cohort, as well as stratified by sex.  
During the six year follow-up interval, 9,087 cohort members died by suicide; the overall suicide 
rate was 34.7 per 100,000 person-years.  Suicide rates were approximately three-fold greater for 
men than women.  The suicide rate among individuals with an SUD diagnosis was 75.6 per 
100,000 person-years; 76.1 per 100,000 person-years for males and 63.4 per 100,000 person-
years for females.  With respect to specific SUDs, the suicide rate associated with sedative use 
disorder was largest, followed by amphetamine, opioid, cannabis, alcohol, and cocaine use 
disorders.  Specific SUD-associated suicide rates followed the same pattern for men.  Among 
women the order differed, with the highest suicide rate observed for sedative use disorder 
followed by opioid, amphetamine, alcohol, cocaine, and cannabis use disorders. 
Results from the sex-stratified proportional hazards regression models estimating 
prospective associations between current SUDs and the risk of suicide during the follow-up 
interval are displayed in Table 3.  In the unadjusted models (Model 1), all current SUDs, as well 
as any current SUD, were significantly associated with increased risk of suicide among both men 
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and women; however, the strength of the association was approximately two-to-three-fold 
greater for women than men.  In post-hoc tests, substance-specific estimates for alcohol, cocaine, 
and opioid use disorders, as well as the estimate for any SUD, were significantly greater for 
women than men (p<0.05).  After adjustment for age group and Charlson Comorbidity (Model 
2), the HR estimates associated with SUDs were marginally attenuated for men and more 
moderately attenuated for women, yet all remained statistically significant.  Furthermore, 
although the same substance-specific HR estimates remained significantly greater for women 
than men in post-hoc tests (p<0.05), the magnitude of the difference was not as pronounced as in 
Model 1.  In the third set of regressions, additional adjustment was made for current co-occurring 
psychiatric diagnoses (Model 3), which further attenuated the SUD HRs.  For men, cocaine use 
disorder became inversely associated with suicide, and for women significant associations 
remained only for alcohol and opioid use disorders, as well as any SUD.  In addition, post-hoc 
analyses revealed that male-female differences were no longer significant for alcohol use 
disorder in Model 3.  
Figure 1 displays method of suicide among all individuals in the cohort who died by 
suicide during the follow-up interval, as well as by current SUD status and sex.  Overall, firearm 
use was the most common method of suicide.  Firearm use was more common among decedents 
without a current SUD diagnosis at baseline than among those with a current SUD diagnosis.  It 
was also more common among males than females.  Poisoning was more common among 
decedents with a current SUD than those without one, as well as more common among women 
than men.  
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Discussion 
In this investigation, we estimated associations between current SUDs and risk of suicide 
in over 4.8 million men and women who used VHA services in FY 2005.  In unadjusted 
analyses, a current diagnosis of any SUD and the specific current diagnoses of alcohol, cocaine, 
cannabis, opioid, amphetamine or other psychostimulant, and sedative, hypnotic or anxiolytic 
use disorders were all associated with elevated risk of suicide for both males and females.  
Further, the relative risk estimates for the relations between any SUD, alcohol, cocaine, and 
opioid use disorders and suicide were markedly stronger for women than men.  However, after 
adjustment for other factors, most notably comorbid psychiatric diagnoses, associations linking 
current SUDs with suicide were attenuated and male-female differences observed in the 
unadjusted models were diminished. 
Although links between SUDs and nonfatal suicide outcomes have been reported in the 
literature, only a limited number of prior studies have examined suicide mortality.  The few 
studies investigating suicide mortality have noted individual associations between any SUD, 
alcohol use disorder, and opioid use disorder and suicide [13].  The present investigation is one 
of the first to provide estimates of the suicide risk associated with current cannabis, cocaine, 
amphetamine, and sedative use disorders in a broad population cohort.  Furthermore, to the best 
of our knowledge, prior work has not concurrently examined links between specific SUDs and 
suicide mortality within the same data source.  Consequently, previous studies have not allowed 
for comparisons in the magnitude of risk associated with specific types of SUDs.  Nor have these 
comparisons been made separately for men and women, despite evidence of sex-differences in 
the risk factors for suicide and the need for greater understanding of SUD and suicide among 
women [13, 20-22].  Findings from the present investigation indicate that associations between 
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SUDs and risk of suicide vary by sex as well as type of SUD.  Among men, the unadjusted 
suicide HRs ranged from 1.35 for cocaine use disorder to 4.74 for sedative use disorder.  Among 
women, there was greater variation in the suicide risk estimates by type of SUD, with HRs 
ranging from 3.89 for cannabis use disorder to 11.36 for sedative use disorder.  Such differences 
may be important for clinicians and health systems to consider when providing care for patients 
with SUDs, and could help inform suicide prevention efforts.  The sizable risk of suicide among 
women with a current opioid use disorder is especially noteworthy, and may be important for 
clinicians to be aware of when treating such patients.   
The marked differences between males and females in the crude SUD-suicide 
associations, as well as the variability in suicide risk between specific types of SUDs, were 
appreciably attenuated after adjustment for co-occurring psychiatric diagnoses.  For instance, the 
HR for suicide associated with a current alcohol use disorder was reduced from 2.26 to 1.64 for 
men and from 4.72 to 1.57 for women after adjustment.  In the case of cocaine use disorder 
among males, the direction of the association was reversed after including other psychiatric 
diagnoses such that cocaine use disorder was associated with a 26% reduction in suicide risk.  
Among women, HRs associated with cocaine and cannabis use disorders approached the null and 
were non-significant after the inclusion of comorbid psychiatric diagnoses.  Previous work has 
found that co-occurring psychopathology may be especially salient among those with a cocaine 
use disorder who attempt suicide [23, 24], and our finding of an inverse association among men 
might be due in part to collinearity between cocaine use disorder and other psychiatric 
conditions; however, further research is needed to better understand suicide mortality among 
those with a cocaine use disorder.  In general, few prior prospective studies examining links 
between SUDs and suicide mortality have taken into account comorbid psychiatric conditions, 
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possibly due to additional sample size requirements beyond those that are already necessary to 
study the rare event of suicide.  However, the previous investigations that have included 
adjustment for other covariates have also noted that underlying psychiatric comorbidity may 
partially explain associations between SUDs and suicide [25].  Collectively, these findings 
highlight the potentially confounding role of comorbid psychiatric illness in SUD-suicide 
associations.  Hence, assessment and treatment of comorbid psychiatric conditions may be 
important in lowering the risk of suicide among individuals with co-occurring SUDs and other 
psychopathology.  Nonetheless, findings from the present investigation suggest that even after 
statistical adjustment for comorbid psychiatric conditions SUDs (in particular, alcohol and opioid 
use disorders) may independently confer excess risk for suicide mortality.  Therefore, SUD 
treatment, including integrated or additional SUD-specific treatment for those with co-occurring 
psychiatric conditions, with assessment and management of suicidal behaviors may be important 
for suicide prevention.  In addition, the findings from the present study regarding method of 
suicide among decedents with SUD highlight the importance of developing strategies to prevent 
intentional poisoning, as well as include firearm safety in suicide prevention efforts, for 
individuals with SUDs.  
Theoretical models regarding suicide risk among individuals with SUDs posit that 
proximal risk for suicide is driven by ongoing substance use, psychiatric symptoms, and 
interpersonal stress [11].  In the present study, the presence of a clinical diagnosis of a co-
occurring psychiatric condition likely reflects a combination of symptoms and 
distress/impairment.  Unfortunately, no data are available on the extent of substance use in the 
present cohort.  However, in the absence of such data, it is possible that much of the risk is 
carried by this clinically significant symptom impairment.  Ideally, future work would be able to 
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model fluctuations in psychiatric symptoms and substance use that might drive suicidal 
behaviors in those with SUDs, as well as the extent to which these fluctuations can be modified 
by treatment.    
There are several limitations that should be considered when interpreting findings from 
the present investigation.  First, the study cohort included all patients who used VHA services in 
a given year.  Previous research has found that individuals who use VHA services may have 
poorer physical and mental health functioning, as well as higher rates of suicide, than those in the 
US general population [4, 26, 27].  Web-based analyses of national injury data from the US 
Centers for Disease Control and Prevention’s (CDC's) Web-based Injury Statistics Query and 
Reporting System (WISQARs) show that the crude suicide rate was 15.56 per 100,000 person 
years for adults aged 20 years and older, and 25.33 per 100,000 person years for males and 6.39 
per 100,000 person years for females, during the same time period as study follow-up (i.e., 2006-
2011)[28].  These crude rates for the US population are lower than those found among our VHA 
cohort.  Consequently, findings may not be generalizable to patient populations from other health 
settings.  Second, although death data are from the NDI, which is the “gold standard” for 
ascertainment of mortality in the US [15], cause of death may still be subject to misclassification.  
In particular, distinguishing between suicide and accidental overdose may be problematic among 
individuals with SUDs, especially among those with opioid use disorders (e.g., [29]).  Third, 
current SUD and other psychiatric diagnoses were obtained from administrative records in the 
NPCD.  Diagnoses are based on VHA providers’ clinical assessment and judgment.  As such, the 
validity and reliability of these current diagnoses are unknown.  Fourth, administrative data used 
in study analyses do not contain information on level of severity of SUDs, which may be 
important to consider in future studies.  It is also possible that the level of severity of SUDs that 
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were diagnosed by providers may have differed between men and women.  Such differences 
could have had an impact on the observed associations between SUDs and suicide.  Fifth, 
analyses were limited to the investigation of suicide risk associated with current SUD diagnoses; 
specific information regarding the extent of drug use including poly drug use is also unavailable 
in VHA administrative data.  Nonetheless, research regarding levels of drug use and poly drug 
use is an important area of suicide research that requires further study [12].  Sixth, given the 
observational, non-randomized nature of the study design, incomplete adjustment for 
confounding factors, measured or unmeasured, is a potential limitation.  Such factors may 
include unreliable or unmeasured demographic variables that were omitted from study analyses.  
We were also unable to account for comorbid SUD diagnoses in analyses due to power concerns, 
especially among women.  Therefore, findings should be interpreted within the context of this 
limitation, and additional research regarding the potential role of co-occurring SUDs on suicide 
is required.  Seventh, study analyses compared individuals with current SUD diagnoses to those 
without current SUD diagnoses.  We were unable to further categorize those without current 
SUD diagnoses into former SUD and never SUD groups.  Further research is needed to examine 
the potential impact of remitted SUDs on suicide risk. 
Despite these limitations, this investigation provides novel and important data regarding 
current SUDs and the risk of suicide.  SUDs may be important markers of suicide risk, especially 
among women, and may be important factors for health systems and clinicians to consider 
including in suicide risk assessment strategies.  Nevertheless, other co-occurring psychiatric 
disorders may partially explain associations between SUDs and suicide, as well as the observed 
excess suicide risk associated with SUDs among women.  
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Table 1. Characteristics of the cohort of FY05 VHA patients alive at the beginning of FY 2006, 
total, and by sex (n=4,863,086) 
  All Male Female 
Characteristic N % N % N % 
Total 4,863,086 100.0 4,460,447 100.0 402,639 100.0 
Age Group 
      
     18-29 158,967 3.3 110,376 2.5 48,591 12.1 
     30-39 245,266 5.0 182,128 4.1 63,138 15.7 
     40-49 514,083 10.6 410,439 9.2 103,644 25.7 
     50-59 1,161,916 23.9 1,057,552 23.7 104,364 25.9 
     60-69 955,689 19.7 915,564 20.5 40,125 10.0 
     70-79 1,136,095 23.4 1,118,723 25.1 17,372 4.3 
     80+ 691,070 14.2 665,665 14.9 25,405 6.3 
Any SUD 386,238 7.9 372,717 8.4 13,521 3.4 
Alcohol Use Disorder 307,923 6.3 298,831 6.7 9,092 2.3 
Cocaine Use Disorder 83,808 1.7 80,565 1.8 3,243 0.8 
Cannabis Use Disorder 56,524 1.2 53,968 1.2 2,556 0.6 
Opioid Use Disorder 37,908 0.8 36,284 0.8 1,624 0.4 
Amphetamine or Other 
Psychostimulant Use 
Disorder  
12,033 0.2 11,321 0.3 712 0.2 
Sedative, Hypnotic or 
Anxiolytic Use Disorder 
7,301 0.2 6,779 0.2 522 0.1 
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Table 2. Overall and SUD-specific suicide mortality and rates among the VHA patient cohort, total, and by sex (n=4,863,086) 




























Overall 9,087 100.0 34.7 8,796 100.0 36.9 291 100.0 12.4 
Any SUD 1,573 17.3 75.6 1,524 17.3 76.1 49 16.8 63.4 
Alcohol Use Disorder 1,259 13.9 76.2 1,231 14.0 76.9 28 9.6 54.0 
Cocaine Use Disorder 231 2.5 49.3 222 2.5 49.3 9 3.1 48.0 
Cannabis Use Disorder 246 2.7 77.4 239 2.7 78.9 7 2.4 47.3 
Opioid Use Disorder 177 1.9 86.9 168 1.9 86.4 9 3.1 98.6 
Amphetamine or Other 
Psychostimulant Use 
Disorder  
64 0.7 95.0 61 0.7 96.5 3 1.0 72.4 
Sedative, Hypnotic or 
Anxiolytic Use Disorder 
66 0.7 171.4 62 0.7 174.1 4 1.4 138.7 
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Table 3. Cox hazards models estimating associations between current SUD and suicide mortality during the follow up interval, FY06 - FY11 (N=4,863,086) 
 
  Model 1* Model 2** Model 3***  
Males  Females Males Females Males Females 
Characteristic HR 95% 
CI 
p HR 95% 
CI 
p HR 95% 
CI 
 
p HR 95% 
CI 
p HR 95% 
CI 
p HR 95% 
CI 
p 
Any SUD 2.29 2.12, 
2.46 
<0.001 5.95 4.29, 
8.26 
<0.001 2.26 2.11, 
2.43 
<0.001 4.82 3.42, 
6.79 
<0.001 1.67 1.55, 
1.79 
<0.001 2.15 1.44, 
3.21 
0.001 
Alcohol Use Disorder 2.26 2.10, 
2.44 
<0.001 4.72 3.15, 
7.06 
<0.001 2.21 2.06, 
2.38 
<0.001 3.73 2.48, 
5.62 
<0.001 1.64 1.52, 
1.76 
<0.001 1.57 1.01, 
2.45 
0.047 
Cocaine Use Disorder 1.35 1.17, 
1.55 
<0.001 3.97 2.13, 
7.39 
<0.001 1.19 1.03, 
1.36 
0.014 2.88 1.50, 
5.50 
0.001 0.74 0.64, 
0.84 
<0.001 1.10 0.57, 
2.15 
0.776 
Cannabis Use Disorder 2.17 1.91, 
2.48 
<0.001 3.89 1.80, 
8.37 
0.001 1.97 1.72, 
2.25 
<0.001 2.90 1.34, 
6.25 
0.007 1.16 1.02, 
1.33 
0.024 1.01 0.45, 
2.26 
0.990 
Opioid Use Disorder 2.37 1.96, 
2.86 
<0.001 8.19 3.74, 
17.95 
<0.001 2.12 1.76, 
2.56 
<0.001 5.90 2.66, 
13.10 
<0.001 1.31 1.08, 
1.58 
0.005 2.33 1.05, 
5.18 
0.038 





<0.001 5.90 2.10, 
16.57 
<0.001 2.32 1.82, 
2.95 
<0.001 4.42 1.52, 
12.91 
0.006 1.30 1.02, 
1.64 
0.032 1.50 0.52, 
4.38 
0.456 
Sedative, Hypnotic or 
Anxiolytic Use Disorder 
4.74 3.64, 
6.17 
<0.001 11.36 3.67, 
35.14 
<0.001 4.26 3.27, 
5.56 
<0.001 8.28 2.69, 
25.53 
<0.001 1.97 1.51, 
2.57 
<0.001 2.41 0.79, 
7.44 
0.127 
*Unadjusted. Covariance sandwich estimators were used to adjust for clustering within VHA facilities. 
**Controlling for age and Charlson Comorbidity Index. Covariance sandwich estimators were used to adjust for clustering within VHA facilities. 
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